This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
In Wednesday’s Flash Talk webinar, we covered recent highlights in covalent drug discovery, with lots of great questions from the…
Article
14 hours ago ●
1 min read
LUNA18: A Clinical, Oral, Cell-Penetrant, Reversible, Macrocyclic Peptide Pan-RAS Inhibitor from mRNA Display LUNA18 is an orally bioavailable, cell-penetrant, macrocyclic…
molecule
4 days ago ●
5 mins read
FLX475: An Azetidine-Containing, First-in-Class CCR4 Candidate with a 72 h Human Half-life RAPT Therapeutics, formerly known as FLX Bio, was…
molecule
1 week ago ●
9 mins read
A First-in-Class TRPA1 Antagonist Overcomes Toxicity Hurdles to Become Cough Candidate Genentech’s GDC-6599 is the first oral TRP Ankyrin 1…
Article
2 weeks ago ●
12 mins read
This month features many of the big reveals from the ACS fall 2023 first disclosures including Nurix’s BTK degrader and…
Article
2 weeks ago ●
2 mins read
A DCAF1 Ligand Designed for Targeted Protein Degradation Targeted protein degraders continue to show differentiation from traditional small molecules in…
molecule
3 weeks ago ●
6 mins read
Load More
